Instrument Inactif

Autres langues GeneNews Ltd Toronto S.E.

Actions

CA36870T2065

Recherche biotechnologique et médicale

Autres langues

21/01	StageZero Announces Partial Revocation of Failure to File Cease Trade Order and Proposed Financing
14/08/25	StageZero Announces Listing on the NEX Exchange
25/07/25	StageZero Announces Delisting from the TSX and a Concomitant Application for Listing on the NEX Exchange
13/05/25	StageZero Life Sciences, Ltd. and ElevationMD Introduce Aristotle and AVRT for the Early Detection of Cancer
13/05/25	StageZero Life Sciences and ElevationMD Introduce Aristotle and AVRT for the Early Detection of Cancer
07/05/25	StageZero Announces Partial Revocation of Cease Trade Order and Proposed Financing
07/05/25	StageZero Life Sciences Ltd. announced that it expects to receive CAD 2 million in funding
16/12/24	GeneNews: Q3 Earnings Snapshot
16/12/24	StageZero Life Sciences, Ltd Announces Q3 2024 Financial Results and Operational Update
16/12/24	StageZero Life Sciences Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024
01/10/24	StageZero Life Sciences, Ltd Announces Q2 2024 Financial Results and Operational Update
30/09/24	GeneNews: Q2 Earnings Snapshot
30/09/24	StageZero Life Sciences Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2024
16/05/24	GeneNews: Q1 Earnings Snapshot
16/05/24	StageZero Life Sciences Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024
09/04/24	Canadian Investment Regulatory Organization Trading Halt - SZLS
08/04/24	StageZero Life Sciences Provides an Update on Application for Management Cease Trade Order
04/12/23	Canadian Investment Regulatory Organization Trading Halt - SZLS.WS
16/11/23	StageZero Life Sciences, Ltd Announces Q3 2023 Financial Results and Operational Update
15/11/23	GeneNews: Q3 Earnings Snapshot
14/11/23	StageZero Life Sciences Ltd. Partners with My One Medical Source and 1,000+ Medical Access Points in the USA
14/11/23	StageZero Life Sciences Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
07/11/23	StageZero Life Sciences, Ltd. Clinical Business Introduces Fourth Pillar to Cancer Offerings
23/10/23	StageZero Life Sciences Clinical Business Introduces Third Pillar to Cancer Offerings
20/10/23	StageZero Life Sciences